What for ?
For setting up a Task Force for Covid Vaccine Distribution
Where is it
reported ?
Following news appearing in today’s Hindustan Times :
What is its task ?
Ø pick the vaccine or vaccines that India can use,
Ø plan the finances for what is sure to be an expensive purchase
running into billions of dollars, and
Ø prioritise the sequence of administration.
Who
are the Members of this Task Force ?
Ø Dr V K Paul – NITI Aayog ( Chair-person )
Ø Shri Rajesh Bhushan , Health Secretary (
Co-Chair )
Ø AIIMS director Dr Randeep Guleria,
Ø Representatives of the ministries of external affairs,
biotechnology, information technology,
Ø Director General of Health services,
Ø India’s Aids Research Institute,
Ø Indian Council of Medical Research,
Ø Representatives from states.
What
are your past suggestions on this subject – especially re Distribution
Priorities ?
Over the past few weeks , I have sent to Cabinet
Ministers / State Chief Ministers / NITI
Aayog etc., following emails :
========================================================
Rationing
of Covid Vaccine ? ………………………………………………………………[ 06 July 2020 ]
Extract :
How to determine these priorities ,
scientifically / un-biasedly , for 700 million people ?
By compiling :
Data about “ Persons already infected ( cured / died / under treatment ) “
Data about “ Persons not infected so far “ – and needing
vaccination
But , if meticulously compiled and centrally processed ( with help
of Artificial Intelligence ),
following data, compiled uniformly at source, could determine those
“ VACCINATION PRIORITIES “ :
[ A ] PERSONAL DATA
Name / Birthdate ( for
Age ) / Gendre / Contact Details / Aadhar number
[ B ] LOCATION DATA
Permanent Address /
Current Address ( State – Jilla – City – locality ) / Red Zone /
Containment
[ C ] FAMILY DATA
Details of Parents /
Siblings
[ D ] HEALTH HISTORY
Details of recent
illnesses - morbidity / Medicines given ( including for Covid
treatment ) / Hospitals where treated / Names
& License Number of Doctor who
treated
[ E ] ETHNIC DATA
Race /
Religion / Language ( Mother tongue )
[ F ] EDUCATIONAL DATA
Graduate – Under
Graduate – Illiterate etc
[ G ] EMPLOYMENT DATA
Employed – Unemployed –
Self employed
[ H ] INCOME DATA
Monthly Income ( to
determine whether RICH – MIDDLE CLASS – POOR )
Besides using such
exhaustive data for all ( Covid infected or not ) in order for AI
software to tell us the
“ priorities for
vaccination “, what else should the
Government do ensure that there is no “ black
marketing “ of the limited
supplies of the vaccine ?
Answer :
Ø
Today , each strip / bottle of a medicine carries “ batch number
“
Ø
For vaccine , each bottle / vial , besides carrying Batch Number
, must carry UNIQUE bottle number / vial
number . Vaccine Manufacturer will record which bottle got dispatched
to which drug store / when. Data will get automatically transmitted to Govt’s
Central Server
Ø
Pharmacy Stores to maintain Computerized Record of who ( which
person ) was sold a given “ Vial Number “ . This data will get automatically
transmitted to Govt’s Central Server
Ø
No vial to be sold to anyone unless a Mobile App (
VaccineVend ? ) clearly displays that person’s priority (
as determined by AI ) , as HIGH / MEDIUM / LOW . No person without such Mobile
App will be sold the vaccine
Ø
Chemist will enter sale-details in customer / buyer’s Mobile App
, which will get automatically transmitted to Govt’s Central Server
=========================================================
An
Appeal to DCGI – and others …………………………………………………………….[ 09 July 2020 ]
=====================================================================================
Thank You
All ……………………………………………………………………………………………[ 10 July 2020 ]
=====================================================================================
RELATED
READINGS :
Centre
plans to set up Covid-19 Registry …………………………………………………( Business Line / 08 Aug 020 )
Extract
:
Ø The Centre is launching a National
Clinical Registry for Covid-19 (NCRC), which will enable collection of real time clinical data for evidence-based clinical practice,
research, formulating guidelines and policy making.
Ø In a letter of intent for participation in the
NCRC, the Indian Council of Medical Research stated that the registry will collect data regarding clinical and laboratory features, treatments and outcomes of Covid-19 patients who are
hospitalised.
Ø Data will also be utilised to study the natural
course of the disease, the spectrum, risk factors, outcomes data in terms of medications and health systems and also behaviour of
Covid-19 in those with tuberculosis and malnutrition. Also, follow up data of
discharged Covid-19 patients will be collected.
Ø ICMR has proposed that data from 100 hospitals will be collected over a duration of one
year. These hospitals must receive at least 100
Covid-19 patients in a month
Ø The registry will help in generating weekly
epidemiological and clinical reports which will
be published on the ICMR website. It will also help in formulating patient management protocols and develop policy guidelines, ICMR stated. It will help understand the
predictors of disease severity and optimise patient management protocols
=====================================================================================
Electronic
Vaccine Intelligence Network ensures essential immunisation services during
Covid-19: Health Ministry
/ Business Line / 04 Aug 2020
=========================================================
Lockdown
hit more workers from lower castes /
Business Line / 04 Aug 2020
=========================================================
I wish you all success in
quickly developing the TECHNOLOGY PLATFORM ( a portal ? ), where all concerned
,
( Hospitals – Nursing Homes
– Isolation Wards – Quarantine Centres – Pathology Labs – Testing Labs – Private
Doctors – Health Workers – Vaccine Administering Staff – Medical Stores –
Vaccine Manufacturers – Distributors – Purchasing Agencies – etc ),
-
enter patient
and vaccine related data , using a STANDARDIZED
/ STRUCTURED , database , as suggested
in :
Corona
Patient Case Histories : a Fragmented Database …………………………..[ 30 Mar 2020 ]
With regards,
Hemen Parekh / hcp@RecruitGuru.com /
08 Aug 2020
=======================================================
Contacts :
Ø Shri Rajesh Bhushan – Health Secretary / secyhfw@nic.in
Ø Shri Anil Deshmukhji ,
Home Minister ( Mah / info@anildeshmukh.com / deshmukhv09@gmail.com )
Ø Shri Rajendra Shinganeji,
FDA Minster ( Mah / drrajendrashingane61@gmail.com )
Ø Shri Arun Unhaleji
FDA Commissioner ( Mah – comm.fda-mah@nic.in )
Ø Shri V G Somani, Drug Controller
General of India ( DCGI )
Ø The Central Drugs Standard Control
Organization ( CDSCO )
Ø Smt Shubhra Singh ,
Chairperson
, The National Pharmaceutical Pricing Authority of India ( NPPA )
Ø Dr T P Lahane, Directorate of Medical
Education and Research ( DMER )